Which one will you choose
Wider than that, though, is a vexed question that has haunted the corridors of sports global anti-doping apparatus for more than two years now: Should semaglutide the active ingredient in Ozempic, Wegovy, and the broader family of GLP-1 receptor agonist medications be added to the World Anti-Doping Agencys Prohibited List
Curr Opin Behav Sci 9:6670 Hayes MR, Skibicka KP, Grill HJ (2008) Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation
The only evidence for dual GLP-1/GIP therapy comes from carefully controlled clinical trials using pre-formulated dual-compound injections with monitored dose escalation
When theres a medication to treat something, it usually means its a disorder or disease, and I think people are starting to see it as such, Bessler said
The key research boundary is simple